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Abstract Diagnosis of paroxysmal atrial fibrillation (AF)
in stroke patients is challenging, but highly clinically rel-
evant. The percentage of stroke patients with permanent
AF increases with age, but limited data are available for the
age-dependent yield of paroxysmal AF by Holter moni-
toring. Patients with acute cerebral ischemia were included
into the prospective observational Find-AF study. Patients
free from AF at presentation received 7 day Holter moni-
toring. We calculated the percentage of otherwise unde-
tected paroxysmal AF and the number needed to screen for
age groups under 60 years, and in 5 year clusters from the
age of 60 up to 85 and older. 272 patients were included, 43
(15.8 %) had AF at admission, 33 patients with paroxysmal
AF were identified by 7 day Holter (n = 29) or medical
history (n = 4).The yield of 7 day Holter ECG clearly
increased with older age (p = 0.004): \60 years: 5 %,
60–64 years: 5 %, 65–69 years: 7 %, 70–74 years: 11 %,
75–79 years: 13 %, 80–84 years: 25 %, C85 years: 39 %.
The number needed to screen (NNS) to find one patient
with paroxysmal AF decreased with age: B60 years: 18,
60–64 years: 20, 65–69 years: 14, 70–74 years: 9,
75–79 years: 8, 80–84 years: 4, C85 years: 3, respectively.
In patients\65 years, all AF cases were detected by Holter
ECG. The percentage of paroxysmal AF in stroke patients
increases with age. The 7 day Holter ECG is most efficient
in elderly patients.
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Introduction
Atrial fibrillation (AF) is a frequent cause of ischemic
stroke and patients with atrial fibrillation bear an increased
risk of stroke recurrence [1, 2].
The yield of AF detection clearly increases by pro-
longing the monitoring interval: In our trial, 7 day Holter
monitoring identified significantly more AF cases than
shorter monitoring intervals [3] and these results are in line
with those of several other trials [4]. Patients with detected
AF show substantial alterations in left atrial size and
function [5] as well as neurohumoral activation [6]. How-
ever, detailed data on the yield of this diagnostic procedure
in relation to age are not available thus far. Hence, the aim
of this study was to evaluate the detection rates of parox-
ysmal AF using 7 day Holter monitoring in relation to the
patients’ age.
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Materials and methods
Patients and AF detection
Find-AF is a single centre prospective observational trial
(ISRCTN 46104198). Patients presenting at the university
hospital of Go¨ttingen, Germany, with signs of cerebral
ischemia were included. Those without AF on baseline
ECG received 7 day Holter monitoring. The recordings
were analysed by specially trained personal and reviewed
by a specialist in cardiac electrophysiology. A clinical
follow-up visit took place after one year. Further details on
the study outline have been published previously [3]. The
study was approved by the local ethic’s committee prior to
inclusion of the first patient. This study complies with the
Declaration of Helsinki and all patients gave written
informed consent.
Definitions and statistical analyses
Continuous data are given as mean ± standard deviation,
categorical variables are given as absolute numbers (per-
cent), unless otherwise stated. Groups were compared by
ANOVA (followed by Tukey’s post hoc test), Mann–
Whitney U test, Chi square test or Fisher’s exact test, as
appropriate. Statistical tests were performed with SPSS
Statistics 20.0.0 (IBM, Chicago, Illinois, USA).
Results
Study population
Two hundred and eighty one consecutive patients were
included, of whom eight had a final diagnosis other than
cerebral ischemia (one of these eight patients presented
with AF) and were excluded from further analysis. One
patient withdrew consent. 43 (15.8 %) of the remaining
272 patients had AF at presentation, the other 229 patients
received 7 day Holter ECG. Paroxysmal AF was detected
in 29 patients (12.6 %), an additional four patients had a
history of paroxysmal AF, but no AF on 7 day Holter ECG.
Clinical characteristics of the complete cohort have pre-
viously been reported [3].
Table 1 shows baseline characteristics (AF on admis-
sion, n = 43; paroxysmal AF n = 33; patients without AF,
n = 196) of the study participants.
As a first finding, baseline characteristics as well as
stroke severity were similar in patients with paroxysmal
AF as compared to patients with AF on admission. Patients
with AF (either paroxysmal or on admission ECG) were
significantly older, they had more severe and more dis-
abling strokes than patients with SR (Table 1).
Age-dependent detection of atrial fibrillation
We formed age clusters and found a clear increase of the
AF rate with age (p \ 0.001). This finding was consistent
for paroxysmal AF as well as for AF on admission ECG
(see Fig. 1). In stroke patients younger than 65 years, all
AF cases were detected by Holter ECG. In patients older
than 65 years, approximately 1/3 of AF patients had par-
oxysmal AF.
Figure 2 shows the 7 day Holter ECG results for all
patients with evaluable Holter ECGs and without a history
of paroxysmal AF (n = 220) as well as the day of first
AF documentation. The diagnostic yield of 7 day Holter
ECG increased with age (p = 0.004), while the number
needed to screen to detect one case of paroxysmal AF
decreased.
Discussion
Our study has three major findings:
1. Patients with paroxysmal AF (newly detected by 7 day
Holter ECG or previously known) show clinical
characteristics and stroke features similar to patients
with permanent AF.
2. The prevalence of paroxysmal AF clearly increases
with age, while the number needed to screen decreases.
3. All AF cases detected in younger patients were
detected by means of prolonged ECG monitoring.
Patients with known AF have more severe strokes [7],
however, previously this was not shown for patients with
paroxysmal AF diagnosed by 7 day Holter ECG. This
finding may be regarded as an indirect hint that patients
with paroxysmal AF [30 s (definition used in this study
according to current guidelines) represent a relevant stroke
subpopulation with equally severely disabling strokes.
It is well established that the risk of stroke in paroxys-
mal and permanent AF is similar and that both groups
equally benefit from primary stroke prevention by means of
oral anticoagulation [7, 8]. However, whether patients
identified by Holter ECG benefit similarly from secondary
prevention therapy (especially anticoagulation) still
remains to be determined [9], but is of major interest for
further research.
Our data are in line with the well-established increase of
AF prevalence with age. However, most available data are
based on standard 12-lead ECGs. This work extends these
findings to a large stroke population with paroxysmal AF
detected by extended Holter monitoring.
The potential role of short AF episodes only to be
diagnosed with intensified cardiac monitoring in causing
stroke and systemic embolism has recently been re-assured
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by the ASSERT trial, which found that even short episodes
of atrial fibrillation ([6 min within 3 months) detected by
long-term evaluation of pacemaker devices with atrial
leads increase the risk of subsequent stroke by 2.5 [10].
All AF episodes in younger patients within our trial
were detected by means of extended Holter-ECG, no
patient \65 presented with AF at baseline or had known
paroxysmal atrial fibrillation. Considering the fact that AF
related strokes show increased stroke severity and young
patients have more quality-adjusted life years at stake, this
subgroup could also significantly benefit from prolonged
monitoring, seeing this method might be their only chance
of identifying AF at all.
Some limitations of our study should be considered.
Find-AF was a non-controlled single centre trial. Only
69 % of patients had evaluable Holter ECG material
[5 days and five Holter ECGs were not evaluable;
hence, the prevalence of paroxysmal AF may be under-
estimated [3]. Other methods, e. g., even more prolonged
spells of Holter monitoring or (implantable) loop
recorders, may have yielded more AF cases, these
methods are currently under investigation [11, 12]. There
were only few young patients with cerebral ischemia and
paroxysmal AF in our population, so that conclusions
regarding this patient group should be re-evaluated in a
larger population.













AF on admission vs.
paroxysmal AF
Age 67 ± 13 76 ± 11 79 ± 6 0.001 0.401
Female gender 82 (41.8 %) 14 (42.4 %) 25 (58.1 %) 1.000 0.247
BMI 27.6 ± 5.9 27.6 ± 5.8 28.1 ± 5.3 0.998 0.932
NIH-SS 2 (1;4) 5 (4;9) 4 (3;8) <0.001 0.611
Modified Rankin Scale 2 (1;3) 3 (2;4) 3 (2;4) 0.021 0.502
Stroke severitya 0.002 0.112
TIA 69 (35.2 %) 3 (9.1 %) 13 (30.2 %)
Minor stroke 54 (27.6 %) 8 (24.2 %) 7 (16.3 %)
Major stroke 73 (37.2 %) 22 (66.7 %) 23 (53.5 %)
TOAST classification <0.001 0.001
Large artery atherosclerosis 39 (19.9 %) 0 (0.0 %) 0 (0.0 %)
Cardioembolic 28 (14.3 %) 15 (45.5 %) 36 (83.7 %)
Lacunar/small vessels 27 (13.8 %) 0 (0.0 %) 0 (0.0 %)
Rare/other causes 5 (2.6 %) 0 (0.0 %) 0 (0.0 %)
Undetermined/multiple Causes 97 (49.5 %) 18 (54.5 %) 7 (16.3 %)
Heart rate (bpm) 72 ± 13 71 ± 16 80 ± 19 0.894 0.013
Systolic blood pressure (mmHg) 144 ± 25 153 ± 25 142 ± 25 0.129 0.161
Diastolic blood pressure (mmHg) 79 ± 13 79 ± 13 84 ± 16 1.000 0.292
Creatinine (mg/dl) 1.0 ± 0.5 1.0 ± 0.5 1.3 ± 0.7 0.921 0.004
Haemoglobin (mg/dl) 13.9 ± 1.7 13.6 ± 2.0 12.9 ± 1.8 0.581 0.172
Left atrial diameter (mm) 41 ± 7 44 ± 6 51 ± 8 0.031 0.001
Left ventricular ejection fraction (%) 62 ± 12 60 ± 10 58 ± 12 0.587 0.824
History of stroke 32 (16.3 %) 5 (15.2 %) 5 (11.6 %) 1.000 0.739
History of TIA 20 (10.2 %) 2 (6.1 %) 4 (9.3 %) 0.749 0.692
Heart failure 10 (5.1 %) 2 (6.1 %) 7 (16.3 %) 0.685 0.284
Hypertension 139 (70.9 %) 28 (84.8 %) 34 (79.1 %) 0.137 0.566
Diabetes mellitus 44 (22.4 %) 7 (21.2 %) 16 (37.2 %) 1.000 0.207
Current Smoker 51 (26.0 %) 4 (12.1 %) 2 (4.7 %)
Hyperlipidaemia 63 (32.1 %) 17 (51.5 %) 13 (30.2 %) 0.047 0.097
Coronary artery disease 22 (11.2 %) 12 (36.4 %) 9 (20.9 %) 0.001 0.196
Peripheral artery disease 5 (2.6 %) 2 (6.1 %) 1 (2.3 %) 0.266 0.576
Bold values indicate statistical significance at p \ 0.05
a Minor stroke: symptoms resolved completely within 30 days or NIH stroke scale changed by B3 points; Major stroke: neurologic deficit
persisted after 30 days or NIH stroke scale score increased by [3 points
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Summary
The prevalence of paroxysmal AF in stroke patients
increases with age. Screening by prolonged Holter ECG is
most efficient in older patients.
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Fig. 1 Cumulative percentage of study participants with no AF
(grey), paroxysmal AF (detected by 7 day Holter or medical history,
orange) and AF on admission ECG (red) in relation to participants’
age
Fig. 2 Percentage of study participants with (previously undiag-
nosed) paroxysmal AF in relation to age. Only participants with no
history of paroxysmal AF and an evaluable 7 day Holter ECG were
included in this analysis (n = 220). NNS number needed to screen to
detect one patient with paroxysmal AF by 7 day Holter ECG within
age groups
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